Skip to the content
Search
Beyond Type 2
Menu
About
Our Story
Founding Partners
Board of Directors
Leadership Council
The Team
Join Us
Contact
Diabetes
Type 1 Info
Type 2 Info
Prediabetes Info
Forms of Diabetes
Newly Diagnosed
Diabetes Management
Pregnancy and Diabetes
Resources
GetInsulin.org
Insulin for T2D
Diabetes Management
Understanding T2D
Exercise
Food
Heart Health
Mental Health
Continuous Glucose Monitoring (CGM)
Veterans with Diabetes
Beyond Type 2 Advocacy
Stories
Diabetes News
Type 2 Stories
Community
En Español
Search
Tag:
ADA2019
New Data Shows FreeStyle Libre Lowers HbA1c in People with T2D
On June 8, Abbott released new data showing the impact of the FreeStyle Libre System on those living with Type 2 diabetes. Research showed that usage significantly reduced hemoglobin A1c (HbA1c) level...
Challenging the Importance of Hypoglycemia in Type 2 Diabetes
A debate between two distinguished professors from the University of Edinburgh and Washington University in St. Louis about the seriousness of hypoglycemia in Type 2 diabetes. Their thoughts just may ...
Results from the PIONEER Program Trials: The First Oral GLP-1 Receptor
The results of the first GLP-1 receptor show it's chances of increasing the risk of cardiovascular events in people with Type 2 diabetes.
Long-Term Effects of Dulaglutide on People with T2D: Results from the REWIND Trial
Researchers reveal the long-term effects of GLP-1 drug on cardiovascular disease in people with type 2 diabetes.
TODAY2 Results: Tracking Type 2 Diabetes in Youth
TODAY was the first multiethnic randomized trial to examine youth-onset Type 2 diabetes. Until the 1990s, cases of Type 2 diabetes (T2D) in children and adolescents were rare. In addition, the increas...
